Our Transactions
Leadership across the largest and most complex situations
Lead Financial Advisor
on its pending ~$26.6 billion sale to
2025
Advising
on its $5.1 billion
sale to
2024
Lead Left Bookrunner
$2.6 billion
Follow-on Offering
2024
Financial Advisor
on its $22.5 billion
acquisition of
2024
Sole Financial Advisor
Ad Hoc Group of First Lien Creditors on
chapter 11 restructuring of $8.1 billion of debt
2024
Lead Financial Advisor
on its €8.0 billion
acquisition of
from Vodafone Group
2024
Advised
on its ~$2.3 billion
acquisition of
2024
Independent Financial Advisor
on its acquisition of three fill-finish sites for an upfront payment of $11 billion from Novo Holdings following its $16.5 billion acquisition of Catalent
2024
Exclusive Financial Advisor
on its pending ~$35 billion
acquisition of
2024
Exclusive Financial Advisor
on its ~$12.6 billion
sale to
2024
Lead Financial Advisor
on its $11.5 billion
all-stock merger with
2024
Lead Financial Advisor
on its ~$13.4 billion
sale to
2023
Financial Advisor
on its pending ~$14.9 billion
sale to
2023
Financial Advisor
on its pending $60 billion
all-stock acquisition of
2023
Active Bookrunner
$1.1 billion IPO & $1.6 billion
Follow-on Offering
2023
Exclusive Financial Advisor
on its pre-packaged chapter 11 restructuring of ~$3.6 billion of debt and preferred equity
2023
Lead Financial Advisor
on its ~$36 billion
spin-off of
2021
Anouncement Date1 |
Status |
Transaction |
Value (M) |
---|---|---|---|
December 30, 2024 |
Pending |
Advising Kestrel Group on its merger with Maiden Holdings |
Up to ~$168 |
December 30, 2024 |
Pending |
Advising Photoneo on its sale to Zebra Technologies |
N/A |
December 24, 2024 |
Announced |
Advised an Ad Hoc Group of lenders on MultiPlan’s comprehensive refinancing transaction |
~$4,900 |
December 23, 2024 |
Pending |
Advising Pacific Century Group on the sale of PineBridge Investments to MetLife Investment Management |
Up to $1,200 |
December 23, 2024 |
Pending |
Advising Inmagene Biopharmaceuticals on its reverse merger with Ikena Oncology |
N/A |
December 20, 2024 |
Pending |
Advising Advent International on its sale of Williams Lea to R.R. Donnelley & Sons Company |
N/A |
December 19, 2024 |
Closed |
Acted as financial adviser to Glide on the refinancing of its existing debt arrangements |
N/A |
December 16, 2024 |
Closed |
Advised Vivendi Group on the spin-off of its subsidiaries Canal+, Havas, and Louis Hachette Group |
€8,402 |
December 16, 2024 |
Pending |
Acting as exclusive financial advisor to Riverstone on the sale of its equity stake in Pattern Energy to a consortium of investors led by APG Asset Management and Australian Retirement Trust |
N/A |
December 16, 2024 |
Closed |
Advised Warburg Pincus on its multi-asset continuation fund |
$2,200 |
December 16, 2024 |
Pending |
Advising Vitesse Energy on its acquisition of Lucero Energy |
$222 |
December 13, 2024 |
Closed |
Advised AIG on the launch of Syndicate 2478 at Lloyd’s of London through a multi-year strategic relationship with Blackstone |
N/A |
December 12, 2024 |
Closed |
Advised Apheon on a continuation fund to acquire interests in TMC and Haudecoeur |
€435 |
December 12, 2024 |
Pending |
Advising Warner Bros. Discovery on its new corporate structure |
N/A |
December 10, 2024 |
Pending |
Advising Gen Digital on its acquisition of MoneyLion |
~$1,000 |
December 9, 2024 |
Closed |
Acted as a Co-Manager on Arthur J. Gallagher & Co.’s Follow-on Offering |
$8,500 |
December 9, 2024 |
Pending |
Advising Boliden on its acquisition of the Zinkgruvan and Neves-Corvo mines from Lundin Mining |
$1,300 |
December 4, 2024 |
Closed |
Acted as a Joint Bookrunner on Amer Sports’ Follow-on Offering |
$1,079 |
December 4, 2024 |
Closed |
Advised Mubadala Investment Company on its significant minority investment in Zelis |
N/A |
December 3, 2024 |
Closed |
Acted as an Active Bookrunner on Crescent Energy’s Follow-on Offering |
$346 |
November 26, 2024 |
Pending |
Advising Tricentis on its significant minority investment from GTCR |
$4,500 |
November 25, 2024 |
Pending |
Advising Summit Materials on its sale to Quikrete |
~$11,500 |
November 25, 2024 |
Pending |
Advising Evelyn Partners on the sale of its Professional Services business to Apax Partners |
N/A |
November 25, 2024 |
Closed |
Advised Oak Re on its significant minority stake sale to Bain Capital |
N/A |
November 25, 2024 |
Pending |
Advising Benchmark Holdings on the sale of its Genetics Business to Novo Holdings |
£260 |
November 24, 2024 |
Pending |
Advising EnLink Midstream on the sale of its outstanding publicly-held common units to ONEOK |
$4,300 |
November 22, 2024 |
Closed |
Advised Court Square Capital Partners on its equity recapitalization of PlayCore |
N/A |
November 22, 2024 |
Pending |
Advising Proximus on the sale of its Luxembourgish TowerCo to InfraRed Capital Partners |
€108 |
November 21, 2024 |
Closed |
Acted as Exclusive Financing Advisor and Placement Agent to Fortress Investment Group on its acquisition of multiple industrial assets |
$450 (financing) |
November 21, 2024 |
Pending |
Advising Innovid on its sale to Mediaocean |
~$525 |
November 20, 2024 |
Closed |
Advised ZeroFox on the sale of its IDX Business to Kingswood Capital Management |
N/A |
November 20, 2024 |
Pending |
Advising LogicMonitor on its significant stake sale to a consortium of investors |
$2,400 |
November 19, 2024 |
Closed |
Acted as an Active Bookrunner on Spyre Therapeutics’ Follow-on Offering |
$200 |
November 18, 2024 |
Pending |
Advising an Ad Hoc Group of Loyalty Noteholders on Spirit Airlines’ pre-arranged Chapter 11 Restructuring |
~$2,285 |
November 18, 2024 |
Closed |
Advised FinThrive Software on its capital raise and debt exchange |
~$1,955 |
November 15, 2024 |
Pending |
Advising OnTrac on its capital raise and comprehensive exchange offer transaction |
~$2,300 |
November 14, 2024 |
Closed |
Advised Molex on its acquisition of AirBorn |
N/A |
November 13, 2024 |
Pending |
Advising Spire Global on the sale of its Maritime business to Kpler |
$241 |
November 12, 2024 |
Pending |
Advising GrafTech International on its new money financing and maturity extension transaction |
$1,450 |
November 12, 2024 |
Closed |
Acted as an Active Book-Running Manager on 89Bio’s Upsized Follow-on Offering |
$125 |
November 11, 2024 |
Pending |
Advising ADIA on its acquisition of a significant minority stake in Qlik from Thoma Bravo |
N/A |
November 11, 2024 |
Pending |
Advising Vialto Partners on its comprehensive out-of-court restructuring |
$1,500 |
November 11, 2024 |
Pending |
Advising Aquis Exchange plc on its sale to SIX Exchange Group ag |
£194 |
November 6, 2024 |
Pending |
Advising Excelitas Technologies on the sale of select aerospace and defense electronics businesses to Teledyne Technologies |
$710 |
November 5, 2024 |
Pending |
Advising Riverside Europe Partners on the sale of Healthtech HTBA to Miura |
N/A |
November 4, 2024 |
Pending |
Advising Ziply Fiber on its sale to Bell Canada |
$5,100 |
November 4, 2024 |
Pending |
Advising Stonepeak Partners on its acquisition of Air Transport Services Group |
$3,100 |
November 1, 2024 |
Closed |
Advised Advent International and Maxar Technologies on the sale of Maxar’s RST business to Arka Group |
N/A |
October 31, 2024 |
Closed |
Advised DAH Gruppe on its dividend recapitalization transaction |
N/A |
October 30, 2024 |
Closed |
Acted as an Active Bookrunner on Vera Therapeutics’ Follow-on Offering |
$345 |
October 29, 2024 |
Closed |
Advised Oportun on its senior secured term loan facility with Castlelake and Neuberger Berman |
$235 |
October 25, 2024 |
Closed |
Acted as a Joint Bookrunner on Ingram Micro’s Initial Public Offering |
$471 |
October 25, 2024 |
Closed |
Acted as Exclusive Global Placement Agent for the fundraise of Nautic Partners XI |
$4,500 |
October 25, 2024 |
Closed |
Acted as Sole Structuring Advisor and Bookrunner to AlpInvest on its Collateralized Fund Obligation issuance |
$1,000 |
October 24, 2024 |
Pending |
Advising Taurus Investment Holdings on the sale of a minority stake to Legal and General |
N/A |
October 18, 2024 |
Pending |
Advising Aquila Air Capital on its sale to Wafra |
N/A |
October 16, 2024 |
Pending |
Advising Lithium Americas on its Investment and Joint Venture Agreement with General Motors |
$625 |
October 15, 2024 |
Pending |
Advising Kestra Holdings on the sale of a majority stake to Stone Point Capital |
N/A |
October 14, 2024 |
Pending |
Advising Longboard Pharmaceuticals on its sale to Lundbeck |
$2,600 |
October 14, 2024 |
Pending |
Advising Centerbridge Partners on its acquisition of Precinmac |
N/A |
October 9, 2024 |
Closed |
Advised Logitix on its sale to Victory Live |
N/A |
October 1, 2024 |
Pending |
Advising TPG on its majority investment in Surescripts |
N/A |
September 30, 2024 |
Closed |
Advised TIH on the sale of its retail insurance broking division, McGriff Insurance, to Marsh McLennan |
$7,750 |
September 30, 2024 |
Pending |
Advising TPG on its acquisition of AT&T’s remaining stake in DirecTV |
$7,600 |
September 23, 2024 |
Closed |
Advised GED Capital on the sale of Envases Soplados to Novapet |
N/A |
September 19, 2024 |
Closed |
Acted as Lead Left Bookrunner on Diamondback Energy’s secondary offering of certain Legacy Endeavor Stockholders’ common stock |
$2,561 |
September 19, 2024 |
Closed |
Acted as Exclusive Financial Advisor to American Rock Salt on its new money super-priority financing transaction |
$110 |
September 18, 2024 |
Pending |
Advising Bel Fuse on its acquisition of a majority stake in Enercon Technologies |
~$320 |
September 18, 2024 |
Pending |
Advising Avenue Capital Group and Nuveen Asset Management on the sale of their minority equity stake in Vistra Vision |
~$3,400 |
September 10, 2024 |
Closed |
Acted as Exclusive Global Placement Agent for the fundraise of FitzWalter Capital Partners II |
~$1,400 |
September 9, 2024 |
Closed |
Advised FlashParking on its special purpose EV charging and parking equipment financing platform |
~$100 |
September 9, 2024 |
Pending |
Advising THL Partners on its majority investment in American Megatrends International |
N/A |
September 4, 2024 |
Closed |
Advised the Ad Hoc Group of Secured Noteholders on Rite Aid’s Chapter 11 Restructuring |
~$4,000 |
September 4, 2024 |
Pending |
Advising Fortive on the tax-free spin-off of its Precision Technologies business |
N/A |
September 3, 2024 |
Pending |
Advising Zellis Group on its acquisition of Benify |
N/A |
September 3, 2024 |
Pending |
Advising Aztec Group on its strategic partnership with, and sale of a minority stake to, Warburg Pincus |
N/A |
August 28, 2024 |
Closed |
Acted as North American, European and Asian Placement Agent for the fundraise of LS Power Equity Partners V |
$2,700 |
August 27, 2024 |
Pending |
Advising Mannok Holdings on its sale to Cimsa Cement |
€330 |
August 27, 2024 |
Pending |
Advising Syniti on its sale to Capgemini |
N/A |
August 19, 2024 |
Closed |
Advised Caerus on its sale to Quantum Capital Group |
~$1,800 |
August 15, 2024 |
Pending |
Advising Blackstone on its acquisition of a majority stake in M3 |
N/A |
August 14, 2024 |
Pending |
Advising The Carlyle Group on the sale of Loc Performance Products to Rheinmetall AG |
$950 |
August 13, 2024 |
Closed |
Advised Universities Superannuation Scheme on its acquisition of Shared Ownership homes from Sage Homes |
£405 |
August 13, 2024 |
Closed |
Advised an Ad Hoc Group of lenders on Brightspeed’s comprehensive recapitalization |
~$6,600 |
August 13, 2024 |
Pending |
Advising CVC Capital Partners on its acquisition of a significant ownership position in Epicor |
N/A |
August 13, 2024 |
Pending |
Advising Haveli Investments and Bregal Milestone on the majority recapitalization of M-Files |
N/A |
August 12, 2024 |
Closed |
Acted as a Joint Bookrunner on Life Time Group Holdings’ Follow-on Offering |
$300 |
August 12, 2024 |
Pending |
Advising QGenda on its sale to Hearst Corporation |
N/A |
August 6, 2024 |
Closed |
Advised Veritas Capital on its acquisition of NCR Voyix’s Digital Banking unit |
$2,450 |
August 1, 2024 |
Closed |
Advised Arcosa on its acquisition of Stavola and concurrent Steel Components business divestiture to Stellex Capital Management |
$1,200 |
August 1, 2024 |
Pending |
Advising Vir Biotechnology on its exclusive license agreement with Sanofi |
Up to ~$2,000 |
July 31, 2024 |
Closed |
Advised Emergent BioSolutions on the sale of its medical countermeasure product RSDL kit to SERB Pharmaceuticals |
$75 |
July 30, 2024 |
Pending |
Advising sennder Technologies on its acquisition of C.H. Robinson’s European Surface Transportation operations |
N/A |
July 29, 2024 |
Pending |
Advising Aquiline Capital Partners on the sale of Quintes Holding to Brown & Brown |
N/A |
July 24, 2024 |
Closed |
Acted as a Joint Bookrunner on Lineage’s Initial Public Offering |
$4,400 |
July 23, 2024 |
Closed |
Advised an Ad Hoc Group of lenders on Belk’s out-of-court recapitalization |
~$1,950 |
July 23, 2024 |
Pending |
Advising Mobileum on its pre-packaged chapter 11 Restructuring |
$628 |
July 22, 2024 |
Closed |
Advised Archrock on its acquisition of Total Operations and Production Services and concurrent equity offering |
$983 |
July 22, 2024 |
Pending |
Advising Goodyear Tire on the sale of its OTR Tire Business to The Yokohama Rubber Company |
$905 |
July 22, 2024 |
Closed |
Advised Krispy Kreme on the sale of a majority of its stake in Insomnia Cookies to Verlinvest and Mistral Equity Partners |
~$175 |
July 19, 2024 |
Pending |
Advising Augmedix on its sale to Commure |
~$139 |
July 9, 2024 |
Pending |
Advising TAIT and its sponsor, Providence Equity Partners, on the sale of a majority stake to Goldman Sachs Alternatives’ Private Equity business |
N/A |
July 8, 2024 |
Closed |
Advised Morphic Therapeutic on its sale to Eli Lilly |
~$3,200 |
July 3, 2024 |
Closed |
Advised OMERS Infrastructure on its sale of LifeLabs to Quest Diagnostics |
C$1,350 |
July 2, 2024 |
Pending |
Advising Isio Group Limited and its sponsor, Exponent Private Equity, on the sale of a majority stake to Aquiline Capital Partners |
N/A |
June 28, 2024 |
Closed |
Advised an Ad Hoc Group of creditors on Cano Health’s chapter 11 Restructuring |
~$1,200 |
June 27, 2024 |
Pending |
Advising CVC on its acquisition of M Group Services |
N/A |
June 27, 2024 |
Closed |
Advised KLAR Partners on the fundraise of KLAR Partners II |
€870 |
June 27, 2024 |
Pending |
Advising Klocke Holding on the sale of IDT Biologika and TEW to SK Bioscience |
~€440 |
June 26, 2024 |
Closed |
Acted as an Active Bookrunner on Webtoon Entertainment’s Initial Public Offering and concurrent private placement |
$392 |
June 26, 2024 |
Pending |
Advising AIG on the sale of its personal travel insurance business (Travel Guard) to Zurich |
~$600 |
June 24, 2024 |
Pending |
Advising Africa Oil on its consolidation of BTG Pactual’s stake in Prime Oil & Gas BV |
N/A |
June 11, 2024 |
Closed |
Advised Tegus on its sale to AlphaSense |
$930 |
June 11, 2024 |
Closed |
Acted as Placement Agent for the fundraise of Latour Capital Fund IV |
€1,200 |
June 11, 2024 |
Closed |
Advised Echo Investment Capital on its mineral asset sale to Sixth Street Partners |
N/A |
June 5, 2024 |
Closed |
Advised HanesBrands on the sale of its global Champion business to Authentic Brands Group |
$1,200 |
June 5, 2024 |
Closed |
Advised Beat Capital Partners on its majority sale to Ambac Financial Group |
$282 |
June 4, 2024 |
Pending |
Advising 2-10 Home Buyers Warranty on its sale to Frontdoor |
$585 |
May 29, 2024 |
Closed |
Advised ConocoPhillips on its acquisition of Marathon Oil Corporation |
$22,500 |
May 29, 2024 |
Pending |
Advising InsurEvo Group on its sale to NSM Insurance Group |
N/A |
May 28, 2024 |
Closed |
Advised 21 Invest France on its two-phase co-control sale and continuation fund transaction for Product Life Group |
€500 |
May 24, 2024 |
Closed |
Advised HPS Group on its acquisition of CR2 |
N/A |
May 23, 2024 |
Pending |
Advising KPS Capital Partners on its acquisition of Tate & Lyle’s remaining ownership interest in Primient |
$350 |
May 22, 2024 |
Closed |
Acted as a Joint Bookrunner on GlobalFoundries’ Follow-on Offering |
~$950 |
May 22, 2024 |
Closed |
Advised SilverBow Resources on its successful proxy fight against Kimmeridge Energy Management Company |
N/A |
May 22, 2024 |
Pending |
Advising Cytokinetics on its strategic financing collaboration with Royalty Pharma |
~$575 |
May 21, 2024 |
Closed |
Advised SRG on its sale to Warburg Pincus and Temasek |
N/A |
May 21, 2024 |
Closed |
Advised an Ad Hoc Group of lenders on Sound Physicians’ debt exchange and new money financing |
~$1,100 |
May 20, 2024 |
Closed |
Advised OSG on its merger with Saltchuk |
$950 |
May 16, 2024 |
Pending |
Advising Priority Software and its sponsors, TA Associates and Fortissimo Capital, on the sale of a majority stake to Blackstone |
N/A |
May 16, 2024 |
Closed |
Advised SilverBow Resources on its sale to Crescent Energy |
$2,100 |
May 14, 2024 |
Closed |
Advised IQGeo Group plc on its recommended cash offer from KKR |
~£333 |
May 13, 2024 |
Closed |
Acted as a Placement Agent to OnKure on its concurrent PIPE financing, as part of its reverse merger with Reneo Pharmaceuticals |
$65 |
May 6, 2024 |
Closed |
Advised Clearlake Capital and Francisco Partners on their acquisition of Synopsys’ Software Integrity Group unit |
~$2,100 |
May 1, 2024 |
Closed |
Advised Texon on its sale to Savage Enterprises |
N/A |
April 30, 2024 |
Closed |
Advised Golub Capital on the fundraise of GEMS Fund 6 |
$2,000 |
April 26, 2024 |
Closed |
Advised Applus' Board of Directors on the competitive tender offer process won by the TDR Capital and I Squared Capital consortium |
~€2,500 |
April 25, 2024 |
Closed |
Acted as Lead Left Bookrunner on AZZ Inc.’s Follow-on Offering |
$322 |
April 24, 2024 |
Closed |
Advised Lightyear Capital on the formation of a single-asset continuation fund for ampliFI Loyalty Solutions |
N/A |
April 23, 2024 |
Closed |
Advised an Ad Hoc Group of First Lien Creditors on Endo International’s chapter 11 restructuring |
~$8,100 |
April 23, 2024 |
Closed |
Advised Vestar Capital Partners on a single-asset continuation vehicle for Circana |
~$1,200 |
April 23, 2024 |
Closed |
Acted as an Active Bookrunner on Centessa Pharmaceuticals' Follow-on Offering |
$100 |
April 22, 2024 |
Closed |
Acted as Exclusive Global Placement Agent for the fundraise of Sterling Group Partners Fund VI |
$3,500 |
April 19, 2024 |
Closed |
Advised an Ad Hoc Group of First Lien lenders on EyeCare Partners’ debt exchange and new money financing |
~$2,450 |
April 18, 2024 |
Closed |
Acted as a Joint Bookrunner on Ibotta’s Initial Public Offering |
$577 |
April 18, 2024 |
Closed |
Advised Revolution Resources on the sale of its Western Anadarko Basin Assets to Benchmark Energy |
$145 |
April 17, 2024 |
Closed |
Acted as Lead Left Bookrunner on Lithium Americas’ Follow-on Offering |
$275 |
April 17, 2024 |
Closed |
Acted as an Active Bookrunner on Montrose Environment Group’s Follow-on Offering |
$128 |
April 15, 2024 |
Pending |
Advising Resideo on its acquisition of Snap One and concurrent investment from CD&R |
$1,400 |
April 15, 2024 |
Pending |
Advising Bain Capital on the sale of Zellis Group to Apax |
N/A |
April 11, 2024 |
Closed |
Acted as Exclusive Global Placement Agent for the fundraise of Maxburg Capital Fund IV |
€450 |
April 9, 2024 |
Closed |
Advised Rimes and EQT on the sale of Rimes to Five Arrows |
N/A |
April 4, 2024 |
Closed |
Advised ConvergeOne on its Restructuring via pre-packaged chapter 11 Bankruptcy |
~$1,800 |
April 2, 2024 |
Closed |
Advised OceanSound Partners on its acquisition of equity interests in SMX Group through a Single-Asset Continuation Fund |
$1,150 |
April 2, 2024 |
Closed |
Acted as the Exclusive Global Placement Agent for the fundraise of Arctos Sports Partners Fund II |
~$4,100 |
April 2, 2024 |
Closed |
Advised KKR on its acquisition of SunFire |
N/A |
March 28, 2024 |
Pending |
Advising Keysight Technologies on its recommended competing cash offer for Spirent Communications |
~£1,200 |
March 28, 2024 |
Closed |
Advised an Ad Hoc Group on Aventiv’s Comprehensive Out-of-Court Restructuring |
~$1,600 |
March 25, 2024 |
Closed |
Advised Nuvation Bio on its acquisition of AnHeart Therapeutics |
~$300 |
March 25, 2024 |
Pending |
Advising n2y on its merger with Texthelp |
N/A |
March 22, 2024 |
Closed |
Advised Triple Private Equity on its acquisition of a majority stake in SmartSearch |
N/A |
March 22, 2024 |
Pending |
Advising HBX Group on the Refinancing & Repricing of its secured term loans |
~€1,600 |
March 20, 2024 |
Closed |
Advised the Coordinating Committee of the Lender Syndicate on EnerMech’s Comprehensive Restructuring Transaction |
N/A |
March 19, 2024 |
Closed |
Acted as a Joint Bookrunner on Astera Labs' Initial Public Offering |
$820 |
March 19, 2024 |
Pending |
Advising the Board of IFF in the context of the sale of its Pharma Solutions business to Roquette |
$2,850 |
March 18, 2024 |
Pending |
Advising Jama Software as the exclusive financial advisor on its sale to Francisco Partners |
$1,200 |
March 18, 2024 |
Closed |
Acted as a Placement Agent for Spyre Therapeutics' PIPE financing |
$180 |
March 15, 2024 |
Closed |
Advised Swisscom on its acquisition of Vodafone Italia from Vodafone Group |
€8,000 |
March 14, 2024 |
Closed |
Acted as an Active Bookrunner on Oddity Tech's Follow-on Offering |
$239 |
March 13, 2024 |
Closed |
Advised Advanced Medical Solutions on its acquisition of Peters Surgical from Eurazeo |
~€141 |
March 13, 2024 |
Closed |
Acted as Global Placement Agent for the fundraise of Wind Point Partners Fund X |
$2,300 |
March 12, 2024 |
Closed |
Advised an Ad Hoc Group on Enviva’s pre-arranged chapter 11 Restructuring |
~$1,800 |
March 6, 2024 |
Closed |
Acted as an Active Bookrunner on Crescent Energy’s Follow-on Offering |
~$145 |
March 6, 2024 |
Closed |
Advised Xeris on the refinancing and upsizing of its existing Senior Secured Term Loan from Hayfin |
$215 |
March 6, 2024 |
Closed |
Advised Corran Capital on its acquisition of a 30% stake in Vital Energi from Scottish Equity Partners |
N/A |
March 5, 2024 |
Closed |
Acted as an Active Bookrunner on Viper Energy’s Follow-on Offering |
~$463 |
March 5, 2024 |
Closed |
Acted as an Active Bookrunner on Akero Therapeutics' Follow-on Offering |
~$367 |
February 29, 2024 |
Closed |
Acted as a Joint Bookrunner on AppLovin’s Follow-on Offering |
$1,113 |
February 29, 2024 |
Closed |
Advised Svenska Petroleum Exploration on its sale to Vaalco Energy |
~$67 |
February 28, 2024 |
Closed |
Advised the Ad Hoc Group of First Lien Lenders on Thrasio’s pre-arranged chapter 11 Restructuring |
~$720 |
February 28, 2024 |
Pending |
Advising DIF, Northleaf and InfraRed on the sale of Northwest Parkway to VINCI Highways |
N/A |
February 26, 2024 |
Closed |
Advised KKR on its acquisition of Broadcom’s End-User Computing Division |
~$4,000 |
February 21, 2024 |
Closed |
Advised Enerplus on its combination with Chord Energy |
~$4,000 |
February 20, 2024 |
Closed |
Advised Walmart on its acquisition of VIZIO |
~$2,300 |
February 20, 2024 |
Closed |
Advised Clayton Dubilier & Rice on its acquisition of Truist Insurance from Truist Financial alongside Stone Point |
$15,500 |
February 16, 2024 |
Closed |
Acted as an Active Bookrunner on GE HealthCare’s Secondary Offering |
$1,230 |
February 15, 2024 |
Closed |
Acted as Exclusive Placement Agent for Sage Geosystem's Series A Capital Raise |
$17 |
February 13, 2024 |
Closed |
Advised Buckthorn Partners on its sale of Coretrax to Expro Group Holdings |
~$210 |
February 12, 2024 |
Closed |
Acted as Global Capital Adviser to Raith Capital Partners on the fundraise for Raith Real Estate Fund III |
$539 |
February 8, 2024 |
Closed |
Acted as a Placement Agent on Mineralys Therapeutics’ Private Placement |
$120 |
February 8, 2024 |
Closed |
Advised Autolus Therapeutics on its Strategic Collaboration with BioNTech to develop, manufacture and commercialize autologous cell therapies |
$250 |
February 6, 2024 |
Closed |
Advised Haveli on its acquisition of ZeroFox |
~$350 |
February 6, 2024 |
Closed |
Acted as an Active Bookrunner on Jasper Therapeutics' Underwritten Equity Offering |
$50 |
February 6, 2024 |
Closed |
Advised Kazyon on its acquisition of a 50% stake in Al Dukan |
SAR 250 |
February 5, 2024 |
Closed |
Advised Novo Nordisk on its acquisition of three fill-finish sites from Novo Holdings following its acquisition of Catalent |
$11,000 |
February 5, 2024 |
Closed |
Advised the Ad Hoc Group of First Lien Term Loan Lenders and Secured Noteholders on GoTo Group’s Exchange Offer |
$3,100 |
February 2, 2024 |
Closed |
Acted as an Active Bookrunner on Vaxcyte’s Follow-on Offering |
$863 |
February 1, 2024 |
Closed |
Acted as an Active Bookrunner on Fractyl Health's Initial Public Offering |
$110 |
January 31, 2024 |
Closed |
Acted as a Joint Bookrunner on Amer Sports’ Initial Public Offering |
$1,570 |
January 30, 2024 |
Closed |
Acted as an Active Bookrunner on Astria Therapeutics' Underwritten Equity Offering |
$125 |
January 30, 2024 |
Closed |
Advised Amphenol on its acquisition of the Carlisle Interconnect Technologies business of Carlisle |
$2,025 |
January 29, 2024 |
Closed |
Acted as an Active Bookrunner on Vera Therapeutics' Follow-on Offering |
$288 |
January 25, 2024 |
Closed |
Acted as Exclusive Global Placement Agent for the fundraise of Arlington Capital Partners Fund VI |
$3,810 |
January 22, 2024 |
Closed |
Advised Hg Capital on its minority stake sale in Argus Media to General Atlantic |
N/A |
January 22, 2024 |
Closed |
Acted as a Placement Agent on Dianthus Therapeutics’ Private Placement Financing |
$230 |
January 18, 2024 |
Closed |
Advised Panera on the sale of Caribou Coffee’s CPG Business to JDE Peet’s |
$260 |
January 17, 2024 |
Closed |
Advised LiveRamp on its acquisition of Habu |
$200 |
January 17, 2024 |
Closed |
Advised PGT Innovations on its sale to MITER Brands |
~$3,100 |
January 16, 2024 |
Pending |
Advising Synopsys on its acquisition of Ansys |
~$35,000 |
January 16, 2024 |
Pending |
Advising Platinum Equity on its sale of the Hunterstown power generation facility to LS Power |
N/A |
January 15, 2024 |
Pending |
Advising Plenoil on the sale of a majority stake to Tensile Capital Management and Portobello Capital |
N/A |
January 12, 2024 |
Closed |
Advised Global Infrastructure Partners on its sale to BlackRock |
~$12,550 |
January 11, 2024 |
Closed |
Advised Chesapeake Energy on its all-stock merger with Southwestern Energy |
$11,500 |
January 10, 2024 |
Pending |
Advising Africa Oil in relation to the farmout of Impact Oil’s offshore Namibia interests to TotalEnergies |
N/A |
January 9, 2024 |
Closed |
Advised Sphera on its acquisition of SupplyShift |
N/A |
January 8, 2024 |
Closed |
Advised Merck on its acquisition of Harpoon Therapeutics |
~$680 |
January 8, 2024 |
Closed |
Advised an Ad Hoc Group of 2L Noteholders on Audacy’s pre-packaged chapter 11 Restructuring |
~$1,900 |
1Announcement date for M&A transactions represents the date publicly announced; announcement date for restructurings represents the date publicly announced or filed; announcement date for capital markets transactions represents the pricing date.